Gemcitabine Functions Epigenetically by Inhibiting Repair Mediated DNA Demethylation

Gemcitabine is a cytotoxic cytidine analog, which is widely used in anti-cancer therapy. One mechanism by which gemcitabine acts is by inhibiting nucleotide excision repair (NER). Recently NER was implicated in Gadd45 mediated DNA demethylation and epigenetic gene activation. Here we analyzed the effect of gemcitabine on DNA demethylation. We find that gemcitabine inhibits specifically Gadd45a mediated reporter gene activation and DNA demethylation, similar to the topoisomerase I inhibitor camptothecin, which also inhibits NER. In contrast, base excision repair inhibitors had no effect on DNA demethylation. In Xenopus oocytes, gemcitabine inhibits DNA repair synthesis accompanying demethylation of oct4. In mammalian cells, gemcitabine induces DNA hypermethylation and silencing of MLH1. The results indicate that gemcitabine induces epigenetic gene silencing by inhibiting repair mediated DNA demethylation. Thus, gemcitabine can function epigenetically and provides a tool to manipulate DNA methylation.

[1]  C. Downes,et al.  Action of etoposide (VP-16-123) on human cells: no evidence for topoisomerase II involvement in excision repair of u.v.-induced DNA damage, nor for mitochondrial hypersensitivity in ataxia telangiectasia. , 1987, Carcinogenesis.

[2]  V. Heinemann,et al.  Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. , 1988, Cancer research.

[3]  J. Nyce.  Drug-induced DNA hypermethylation and drug resistance in human tumors. , 1989, Cancer research.

[4]  M. Ptashne,et al.  A vector for expressing GAL4(1-147) fusions in mammalian cells. , 1989, Nucleic acids research.

[5]  Y Z Xu,et al.  Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. , 1990, Molecular pharmacology.

[6]  J. Bollinger,et al.  2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase. , 1991, Journal of medicinal chemistry.

[7]  R. Momparler,et al.  Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells , 1991, Anti-cancer drugs.

[8]  L. Hertel,et al.  Action of 2',2'-difluorodeoxycytidine on DNA synthesis. , 1991, Cancer research.

[9]  R. Treisman,et al.  The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain , 1993, Cell.

[10]  V. Heinemann,et al.  Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism. , 1995, Seminars in oncology.

[11]  Benjamin Rs.  Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism. , 1995 .

[12]  J. Nyce,et al.  Drug-induced DNA hypermethylation: a potential mediator of acquired drug resistance during cancer chemotherapy. , 1997, Mutation research.

[13]  P. Laird,et al.  COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.

[14]  M. Toyota,et al.  CpG island methylator phenotypes in aging and cancer. , 1999, Seminars in cancer biology.

[15]  M. James,et al.  Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. , 1999, Nucleic Acids Research.

[16]  M. Ehrlich,et al.  Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. , 1999, Mutation research.

[17]  H. Jiang,et al.  Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  P. D'Arpa,et al.  Mechanism of Action of Camptothecin , 1996, Annals of the New York Academy of Sciences.

[19]  L. Feng,et al.  Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. , 2001, Cancer research.

[20]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[21]  S. Weitman,et al.  Enhancement of DNA ligase I level by gemcitabine in human cancer cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  A. Escargueil,et al.  Catalytic topoisomerase II inhibitors in cancer therapy. , 2003, Pharmacology & therapeutics.

[23]  C. Cullinane,et al.  Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines. , 2003, Molecular pharmacology.

[24]  H. Döhner,et al.  Capillary electrophoretic analysis of genomic DNA methylation levels. , 2003, Nucleic acids research.

[25]  J. Schellens,et al.  DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. , 2003, Biochemical pharmacology.

[26]  M. Sternberg,et al.  Isolation of a small molecule inhibitor of DNA base excision repair , 2005, Nucleic acids research.

[27]  F. Cappuzzo,et al.  Role of gemcitabine in cancer therapy. , 2005, Future oncology.

[28]  Kentaro Yamashita,et al.  Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.

[29]  Y. Seo,et al.  Base excision DNA repair defect in Gadd45a-deficient cells , 2007, Oncogene.

[30]  Christof Niehrs,et al.  Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation , 2007, Nature.

[31]  B. Cairns,et al.  DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45 , 2008, Cell.

[32]  F. Lyko,et al.  Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine , 2008, International journal of cancer.

[33]  Vladimir Benes,et al.  Transient cyclical methylation of promoter DNA , 2008, Nature.

[34]  D. Maloney,et al.  Inhibitors of DNA polymerase beta: activity and mechanism. , 2008, Bioorganic & medicinal chemistry.

[35]  G. Pfeifer,et al.  GADD45A Does Not Promote DNA Demethylation , 2008, PLoS genetics.

[36]  G. Ming,et al.  Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis , 2009, Science.

[37]  M. Dolan,et al.  Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity , 2009, Molecular Cancer Therapeutics.

[38]  M. Surani,et al.  Genome-Wide Reprogramming in the Mouse Germ Line Entails the Base Excision Repair Pathway , 2010, Science.